Depolarization of endothelial cells enhances platelet aggregation through oxidative inactivation of endothelial NTPDase

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 22, Issue 12, 2002, Pages 2003-2009

  Krötz, Florian ^a   Sohn, Hae Young ^a,b   Keller, Matthias ^a,b   Gloe, Torsten ^a   Bolz, Steffen Sebastian ^a   Becker, Bernhard F ^a   Pohl, Ulrich ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Chronic depolarization; Ectonucleotidases; Ectonueleotidases; Endothelium; Platelet aggregation; Superoxide

Indexed keywords

ADENOSINE DIPHOSPHATE; ADENOSINE PHOSPHATE; ALPHA,BETA METHYLENE 5' DIPHOSPHATE; ECTONUCLEOTIDASE; ENZYME INHIBITOR; GRAMICIDIN; NUCLEOTIDASE; PHOSPHATE; SUPEROXIDE DISMUTASE; TETRABUTYLAMMONIUM; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTERY RESISTANCE; ARTICLE; BLOOD PRESSURE; CELL LINE; CELL VIABILITY; CONTROLLED STUDY; DEPOLARIZATION; ENDOTHELIUM CELL; ENZYME ACTIVITY; ENZYME INACTIVATION; HUMAN; HUMAN CELL; MEMBRANE POTENTIAL; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN EXPRESSION; SYRIAN HAMSTER; THROMBOCYTE AGGREGATION;

ADENOSINE DIPHOSPHATE; ANIMALS; ANTIGENS, CD; APYRASE; ARTERIOLES; BLOTTING, WESTERN; CELL LINE; CELL SURVIVAL; CRICETINAE; CULTURE MEDIA, CONDITIONED; ENDOTHELIUM, VASCULAR; ENZYME REPRESSION; HUMANS; MEMBRANE POTENTIALS; MESOCRICETUS; OXIDATION-REDUCTION; PHOSPHATES; PLATELET AGGREGATION; SUPEROXIDES; UMBILICAL VEINS;

EID: 0036924462     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.0000043454.08172.51     Document Type: Article

References (46)

1. Fuster V, Badimon L, Badimon JJ, Chesebro JH. The pathogenesis of coronary artery disease and the acute coronary syndromes (2). N Engl J Med. 1992;326:310-318.
2. Ross R. The pathogenesis of atherosclerosis: A perspective for the 1990s. Nature. 1993;362:801-809.
3. Siess W. Molecular mechanisms of platelet activation. Physiol Rev. 1989;69:58-178.
4. Valles J, Santos MT. Aznar J, Martinez M, Moscardo A, Pinon M, Broekman MJ, Marcus AJ. Platelet-erythrocyte interactions enhance alpha(IIb)beta(3) integrin receptor activation and P-selectin expression during platelet recruitment: Down-regulation by aspirin ex vivo. Blood. 2002;99:3978-3984.
5. Santos MT, Valles J, Marcus AJ, Saifer LB, Broekman MJ, Islam N, Ullman HL, Eiroa AM. Aznar J. Enhancement of platelet reactivity and modulation of eicosanoid production by intact erythrocytes: A new approach to platelet activation and recruitment. J Clin Invest. 1991:87:571-580.
6. Gayle RB, Maliszewski CR, Gimpel SD, Schoenborn MA, Caspary RG, Richards C, Brasel K, Price V, Drosopoulos JH, Islam N, Alyonycheva TN, Broekman MJ, Marcus AJ. Inhibition of platelet function by recombinant soluble ecto-ADPase/CD39. J Clin Invest. 1998:101:1851-1859.
7. Enjyoji K, Sevigny J, Lin Y, Frenette PS, Christie PD, Esch JS, Imai M, Edelberg JM, Rayburn H, Lech M. Beeler DL, Csizmadia E, Wagner DD, Robson SC, Rosenberg RD. Targeted disruption of cd39/ATP diphosphohydrolase results in disordered hemostasis and thromboregulation. Nat Med. 1999;5:1010-1017.
8. Pinsky DJ. Broekman MJ, Peschon JJ, Stocking KL, Fujita T, Ramasamy R, Connolly ES Jr, Huang J,. Kiss S. Zhang Y, Choudhri TF, McTaggart RA, Liao H, Drosopoulos JH, Price VL,. Marcus AJ, Maliszewski CR. Elucidation of the thromboregulatory role of CD39/ectoapyrase in the ischemic brain. J Clin Invest. 2002:109:1031-1040.
9. Zimmermann H. Extracellular metabolism of ATP and other nucleotides. Naunyn Schmiedebergs Arch Pharmacol. 2000;362:299-309.
10. Marcus AJ, Broekman MJ, Drosopoulos JH, Islam N. Alyonycheva TN. Safier LB, Hajjar KA, Posnett DN. Schoenborn MA, Schooley KA, Gayle RB, Maliszewski CR. The endothelial cell ecto-ADPase responsible for inhibition of platelet function is CD39. J Clin Invest. 1997:99:1351-1360.
11. Kaczmarek E. Koziak K. Sevigny J, Siegel JB. Anrather J, Beaudoin AR, Bach FH, Robson SC. Identification and characterization of CD39/vascular ATP diphosphohydrolase. J Biol Chem. 1996;271:33116-33122.
12. Sevigny J, Sundberg C, Braun N, Guckelberger O, Csizmadia E. Qawi I, Imai M, Zimmermann H, Robson SC. Differential catalytic properties and vascular topography of murine nucleoside triphosphate diphosphohydrolase 1 (NTPDasel) and NTPDase2 have implications for thromboregulation. Blood. 2002;99:2801-2809.
13. Qawi I, Robson SC. New developments in anti-platelet therapies: Potential use of CD39/vascular ATP diphosphohydrolase in thrombotic disorders. Curr Drug Targets. 2001:2:213-214.
14. Robson SC, Kaczmarek E, Siegel JB, Candinas D, Koziak K, Millan M, Hancock WW, Bach FH. Loss of ATP diphosphohydrolase activity with endothelial cell activation. J Exp Med. 1997;185:153-163.
15. Candinas D, Koyamada N. Miyatake T, Siegel J, Hancock WW. Bach FH. Robson SC. Loss of rat glomerular ATP diphosphohydrolase activity during reperfusion injury is associated with oxidative stress reactions. Thromb Haemost. 1996;76:807-812.
16. Sohn HY, Keller M, Gloe T, Morawietz H, Rueckschloss U, Pohl U. The small G-protein Rac mediates depolarization-induced superoxide formation in human endothelial cells. J Biol Chem. 2000:275:18745-18750.
17. 2- entry, and gene expression in cerebral arteries of hypertensive rats. Am J Physiol Heart Circ Physiol. 2001;281:H2559-H2567.
18. Fukao M, Hattori Y, Kanno M, Sakuma I, Kitabatake A. Alterations in endothelium-dependent hyperpolarization and relaxation in mesenteric arteries from streptozotocin-induced diabetic rats. Br J Pharmacol. 1997;121:1383-1391.
19. Kohler R, Brakemeier S. Kuhn M, Behrens C, Real R, Degenhardt C, Orzechowski HD, Pries AR, Paul M. Hoyer J. Impaired hyperpolarization in regenerated endothelium after balloon catheter injury. Circ Res. 2001;89:174-179.
20. Harder DR. Pressure-induced myogenic activation of cat cerebral arteries is dependent on intact endothelium. Circ Res. 1987;60:102-107.
21. Gloe T, Riedmayr S. Sohn HY,. Pohl U. The 67-kDa laminin-binding protein is involved in shear stress-dependent endothelial nitric-oxide synthase expression. J Biol Chem. 1999;274:15996-16002.
22. Krotz F, Sohn HY. Gloe T, Zahler S, Riexinger T, Schiele TM, Becker BF. Theisen K, Klauss V, Pohl U. NAD(P)H oxidase-dependent platelet superoxide anion release increases platelet recruitment. Blood. 2002:100:917-924.
23. Baykov AA, Evtushenko OA, Avaeva SM. A malachite green procedure for orthophosphate determination and its use in alkaline phosphatase-based enzyme immunoassay. Anal Biochem. 1988:171:266-270.
24. 2- during acetylcholine-induced dilation of microvessels. Br J Pharmacol. 1999;128:124-134.
25. Beach JM, McGahren ED, Xia J, Duling BR. Ratiometric measurement of endothelial depolarization in arterioles with a potential-sensitive dye. Am J Physiol. 1996;270:H2216-H2227.
26. Cote YP, Filep JG, Battistini B, Gauvreau J, Sirois P, Beaudoin AR. Characterization of ATP-diphosphohydrolase activities in the intima and media of the bovine aorta: Evidence for a regulatory role in platelet activation in vitro. Biochim Biophys Acta. 1992;1139:133-142.
27. Koziak K, Sevigny J, Robson SC, Siegel JB, Kaczmarek E. Analysis of CD39/ATP diphosphohydrolase (ATPDase) expression in endothelial cells, platelets and leukocytes. Thromb Haemost. 1999;82:1538-1544.
28. Bakker WW, Willink EJ, Donga J, Hulstaert CE, Hardonk MJ. Antithrombotic activity of glomerular adenosine diphosphatase in the glomerular basement membrane of the rat kidney. J Lab Clin Med. 1987;109:171-177.
29. Poelstra K, Hardonk MJ, Koudstaal J, Bakker WW. Intraglomerular platelet aggregation and experimental glomerulonephritis. Kidney Int. 1990;37:1500-1508.
30. Wolin MS. Interactions of oxidants with vascular signaling systems. Arterioscler Thromb Vasc Biol. 2000:20:1430-1442.
31. Schulte Am EJ, Sevigny J, Kaczmarek E, Siegel JB, Imai M, Koziak K, Beaudoin AR, Robson SC. Structural elements and limited proteolysis of CD39 influence ATP diphosphohydrolase activity. Biochemistry. 1999;38:2248-2258.
32. Stout JG, Kirley TL. Control of cell membrane ecto-ATPase by oligomerization state: Intermolecular cross-linking modulates ATPase activity. Biochemistry 1996;35:8289-8298.
33. Asai T, Miura S, Sibley LD, Okabayashi H, Takeuchi T. Biochemical and molecular characterization of nucleoside triphosphate hydrolase isozymes from the parasitic protozoan Toxoplasma gondii. J Biol Chem. 1995;270:11391-11397.
34. Stommel EW, Cho E, Steide JA,. Seguin R, Barchowsky A, Schwartzman JD, Kasper LH. Identification and role of thiols in Toxoplasma gondii egress. Exp Biol Med (Maywood). 2001:226:229-236.
35. Plesner L. Ecto-ATPases: Identities and functions, Int Rev Cytol. 1995;158:141-214.
36. Kawashima Y, Nagasawa T, Ninomiya H. Contribution of ecto-5′-nucleotidase to the inhibition of platelet aggregation by human endothelial cells. Blood. 2000;96:2157-2162.
37. Wolin MS, Gupte SA, Oeckler RA. Superoxide in the vascular system. J Vasc Res. 2002:39:191-207.
38. Sobey CG. Potassium channel function in vascular disease. ArteriosclerThromb Vasc Biol. 2001:21:28-38.
39. Beny J. Electrical coupling between smooth muscle cells and endothelial cells in pig coronary arteries. Pflugers Arch. 1997;433:364-367.
40. Beny JL, Pacicca C. Bidirectional electrical communication between smooth muscle and endothelial cells in the pig coronary artery. Am J Physiol. 1994:266:H1465-H1472.
41. Schnackenberg CG, Welch WJ, Wilcox CS. Normalization of blood pressure and renal vascular resistance in SHR with a membrane-permeable superoxide dismutase mimetic: Role of nitric oxide. Hypertension. 1998:32:59-64.
42. Guzik TJ, Mussa S, Gastaldi D, Sadowski J, Ratnatunga C, Pillai R, Channon KM. Mechanisms of increased vascular superoxide production in human diabetes mellitus: Role of NAD(P)H oxidase and endothelial nitric oxide synthase. Circulation. 2002:105:1656-1662.
43. Andersen OS. Gramicidin channels. Annu Rev Physiol. 1984:46:531-548.
44. Robson SC, Daoud S, Begin M, Cote YP, Siegel JB, Bach FH, Beaudoin AR. Modulation of vascular ATP diphosphohydrolase by fatty acids. Blood Coagul Fibrinolysis. 1997;8:21-27.
45. Campbell WB, Gebremedhin D, Pratt PF, Harder DR. Identification of epoxyeicosatrienoic acids as endothelium-derived hyperpolarizing factors. Circ Res. 1996:78:415-423.
46. (2+) changes and dilation in isolated resistance arteries. FASEB J. 2000;14:255-260.